Prognostic value of interleukin-6 during a 3-year follow-up in patients with acute ST-segment elevation myocardial infarction.
Tan, Jing
Prognostic value of interleukin-6 during a 3-year follow-up in patients with acute ST-segment elevation myocardial infarction. [electronic resource] - Heart and vessels Sep 2009 - 329-34 p. digital
Publication Type: Journal Article
1615-2573
10.1007/s00380-008-1128-8 doi
Aged
Aged, 80 and over
Biomarkers--blood
CD40 Ligand--blood
Enzyme-Linked Immunosorbent Assay
Female
Follow-Up Studies
Humans
Inflammation Mediators--blood
Interleukin-6--blood
Kaplan-Meier Estimate
Logistic Models
Male
Matrix Metalloproteinase 9--blood
Middle Aged
Myocardial Infarction--immunology
Patient Admission
Predictive Value of Tests
Prospective Studies
Risk Assessment
Risk Factors
Time Factors
Tissue Inhibitor of Metalloproteinase-1--blood
Treatment Outcome
Up-Regulation
Prognostic value of interleukin-6 during a 3-year follow-up in patients with acute ST-segment elevation myocardial infarction. [electronic resource] - Heart and vessels Sep 2009 - 329-34 p. digital
Publication Type: Journal Article
1615-2573
10.1007/s00380-008-1128-8 doi
Aged
Aged, 80 and over
Biomarkers--blood
CD40 Ligand--blood
Enzyme-Linked Immunosorbent Assay
Female
Follow-Up Studies
Humans
Inflammation Mediators--blood
Interleukin-6--blood
Kaplan-Meier Estimate
Logistic Models
Male
Matrix Metalloproteinase 9--blood
Middle Aged
Myocardial Infarction--immunology
Patient Admission
Predictive Value of Tests
Prospective Studies
Risk Assessment
Risk Factors
Time Factors
Tissue Inhibitor of Metalloproteinase-1--blood
Treatment Outcome
Up-Regulation